Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-21-034187

President & CEO sold 11,560 shares at $18.30 ($211,548)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
ROBIN HOWARD W President & CEO 2021-05-17 Sale −11,560 $18.30 $211,548 435,638 D
Open-market sales · 11,560 sh · avg $18.30 · $211,548
Loading xslF345X03/doc4.xml…